Showing 1891-1900 of 2657 results for "".
- Kala Bio Announces Chief Executive Officer Transitionhttps://modernod.com/news/kala-bio-announces-chief-executive-officer-transition/2482662/Kala Bio announced the resignation of Chief Executive Officer Mark Iwicki, and the appointment of Todd Bazemore, Kala's President and Chief Operating Officer, as interim CEO, effective immediately. Mr. Iwicki will continue to serve as Chair of the Board of Directors of Kala fol
- TECLens Secures $9.3 Million Series A Funding to Advance Its Noninvasive Refractive Technologyhttps://modernod.com/news/teclens-secures-93-million-series-a-funding-to-advance-its-noninvasive-refractive-technology/2482658/TECLens announced it raised $9.3 million in a Series A round to support the clinical development of the company’s non-incisional refractive correction procedure that leverages corneal cross-linking (CXL) to reshape the cornea. The funding round was co-led by Johnson &
- AEYE Health and Topcon Healthcare Announce Results of Autonomous DR Screening Studyhttps://modernod.com/news/aeye-health-partners-with-topcon-healthcare-announce-results-of-autonomous-dr-screening-technology/2482657/AEYE Health and Topcon Healthcare announced results of a recent study evaluating Topcon’s NW500 non-mydriatic retinal camera and AEYE Diagnostic Screening (AEYE-DS). In the study, the AEYE-DS AI technology, in conjunction with the Topcon
- DigitalOptometrics to Preview 'World’s First Autonomous Slitlamp' at Vision Expo East 2025https://modernod.com/news/digitaloptometrics-to-preview-worlds-first-autonomous-slitlamp-at-vision-expo-east-2025/2482655/DigitalOptometrics has announced the launch of what it is calling the world’s first and most advanced autonomous slitlamp with remote control capabilities at Vision Expo East (VEE) 2025 in Orlando. In collaboration with SlitLED, DigitalOptometrics will demonstrate t
- CoFi Reaches New Milestone: 10,000 Vision Providers are Now Active on CoFi’s Multi-Party Payment Platformhttps://modernod.com/news/cofi-reaches-new-milestone-10000-vision-providers-are-now-active-on-cofis-multi-party-payment-platform/2482648/CoFi announced it has reached a new milestone of more than 10,000 ophthalmologists and optometrists active on the CoFi platform. Since CoFi’s commercial launch in the summer of 2021, the company has been growing rapidly, with nearly 200 new vision practices joining the platform each month i
- FDA Approves Susvimo for Diabetic Macular Edema (DME)https://modernod.com/news/fda-approves-susvimo-for-diabetic-macular-edema-dme/2482646/The FDA has approved Genentech's Susvimo ocular implant (ranibizumab) 100 mg/mL for the treatment of diabetic macular edema (DME). The approval makes Susvimo the first and only FDA-approved treatment shown to maintain vision in people with DME with fewer treatments than standard-of-
- Iantrek Announces First Commercial Cases of C.Rex Micro-Interventional System for Trabecular Outflow Enhancementhttps://modernod.com/news/iantrek-announces-first-commercial-cases-of-crex-micro-interventional-system-for-trabecular-outflow-enhancement/2482640/Iantrek announced the completion of the first commercial cases utilizing its C.Rex micro-interventional system for canal outflow enhancement in glaucoma surgery. Iantrek said the milestone marks the beginning of the company's pre-launch activities for the C.Re
- Surgilūm's RoboMarker G2 Receives 5 International Medical Device Design Awardshttps://modernod.com/news/surgilums-robomarker-g2-receives-5-international-medical-device-design-awards/2482638/Surgilūm's RoboMarker G2 was awarded international medical device design awards by 3 associations. The awards include: New York Product Design Award: an international competition celebrating excellence in product desi
- Norlase Receives FDA 510(k) Clearance and CE Mark for LYNX Pattern Scanning Laser Indirect Ophthalmoscopehttps://modernod.com/news/norlase-receives-fda-510k-clearance-and-ce-mark-for-lynx-pattern-scanning-laser-indirect-ophthalmoscope/2482634/Norlase announced the FDA 510(k) clearance and CE Mark for Norlase LYNX, which the company describes as the world’s first and only pattern scanning laser indirect ophthalmoscope. Commercially available now, the LYNX is battery-powered and provides surgeons the abili
- MERIT Acquires OSOD to Expand Ophthalmic Drug Development Serviceshttps://modernod.com/news/merit-acquires-osod-to-expand-ophthalmic-drug-development-services/2482629/MERIT announced its has acquired OSOD, which assists with ophthalmic preclinical drug development. The acquisition enhances MERIT’s capabilities, enabling a transition from preclinical to clinical phases of drug development. Accordin